Cantel Medical Corp. Cl B | Balance Sheet

Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
34,076.00
31,781.00
31,720.00
28,367.00
36,584.00
94,097
Total Accounts Receivable
53,860.00
62,225.00
69,805.00
93,332.00
110,656.00
118,642
Inventories
54,167.00
59,737.00
72,078.00
91,486.00
98,724.00
107,592
Other Current Assets
8,557.00
10,166.00
14,758.00
9,557.00
11,407.00
17,912
Total Current Assets
150,660.00
163,909.00
188,361.00
222,742.00
257,371.00
338,243
Net Property, Plant & Equipment
46,465.00
52,718.00
62,541.00
74,604.00
88,338.00
111,417
Total Investments and Advances
-
-
660.00
-
-
-
Intangible Assets
287,547.00
314,599.00
327,787.00
392,037.00
435,957.00
505,388
Other Assets
2,999.00
4,919.00
4,682.00
5,149.00
4,707.00
5,749
Total Assets
490,528.00
544,943.00
591,583.00
710,738.00
805,698.00
963,708
ST Debt & Current Portion LT Debt
10,000.00
-
162.00
165.00
-
Accounts Payable
13,322.00
19,529.00
16,184.00
26,263.00
27,469.00
Income Tax Payable
-
893.00
2,468.00
4,061.00
3,167.00
Other Current Liabilities
35,829.00
46,077.00
51,810.00
65,846.00
76,143.00
Total Current Liabilities
59,151.00
66,499.00
70,624.00
96,335.00
106,779.00
Long-Term Debt
85,000.00
80,500.00
78,910.00
116,250.00
126,000.00
Provision for Risks & Charges
-
-
2,199.00
1,201.00
-
Deferred Taxes
21,186.00
17,805.00
23,722.00
23,579.00
24,714.00
Other Liabilities
1,202.00
6,095.00
1,943.00
2,797.00
4,948.00
Total Liabilities
169,396.00
179,697.00
184,950.00
256,368.00
281,766.00
Common Equity (Total)
321,132.00
365,246.00
406,633.00
454,370.00
523,932.00
Total Shareholders' Equity
321,132.00
365,246.00
406,633.00
454,370.00
523,932.00
Total Equity
321,132.00
365,246.00
406,633.00
454,370.00
523,932.00
Liabilities & Shareholders' Equity
490,528.00
544,943.00
591,583.00
710,738.00
805,698.00

About Cantel Medical

View Profile
Address
150 Clove Road
Little Falls New Jersey 07424
United States
Employees -
Website http://www.cantelmedical.com
Updated 07/08/2019
Cantel Medical Corp. engages in the provision, development, and manufacture of infection prevention products and services in the healthcare market. It operates through the following business segments: Endoscopy; Water Purification and Filtration; Healthcare Disposables; Dialysis; and Other. The Endoscopy segment includes endoscope reprocessing and endoscopy procedure products.